HKUMed (IMAGE)

The University of Hong Kong

HKUMed

Caption

HKUMed has pioneered a ‘dual immunotherapy’ combination for treating liver cancer patients since 2016, significantly improving survival rates and tumour control. (From left) Professor Cheung Tan-to, Dr Thomas Yau Chung-cheung, patients Mr Ng and Mr Lee, and Dr Ronald Leung Ching-yu.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.